Will India’s Semaglutide boom create more losers than winners?
With prices falling by as much as 90% and early movers locking in prescribers, the market may be heading for a sharp shakeout, leaving little room for late entrants, according to an Impeerical Consulting report
With prices falling by as much as 90% and early movers locking in prescribers, the market may be heading for a sharp shakeout, leaving little room for late entrants, according to an Impeerical Consulting report
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
